VSVG Protein- Drosophila VSVG NJ Recombinant Protein from ProteoGenix; catalogue PX-P2099; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Vesicular stomatitis virus (VSV) glycoproteins mediate both cell attachment and membrane fusion. Unlike many other low-pH-induced viral fusion proteins, their fusogenic conformational transitions is reversible. VSV-G has a three-stage fusion kinetics:
I. G-protein conformational change which is reversible and pH-dependent.
II. Reversible trimerization and clustering of the G-protein fusion loops.
III. Folding back of a cluster of extended trimers into their post-fusion conformations.
VSV NJ glycoprotein contains 517 amino acids and is glycosylated at position 178 and 335. Unlike VSV Indiana (VSIV), another major serotype of VSV, VSV NJ is not acylated. The two serotypes also differentiate in terms of antigenic structure. VSV NJ has a faster glycoprotein folding intracellularly and with less dependence on glycosylation.
ProteoGenix catalogue number PX-P2099. For research use only.
Host: Insect; Expression system: Eukaryotic expression; Purity: 90%; Molecular weight: 59.11kDa; Tag: Yes; Fragment: Full-length; Buffer: PBS, pH 7.5; Applications: WB, ELISA.
Available configurations: 50ug, 100ug.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
